After the occurrence of diabetes in patients, with the increase of the course of disease and the increase of the age of patients, the incidence of other combined diseases in patients is also increasing. Diabetes combined with hyperuricemia is a common clinical disease, and 40% of patients with diabetes will develop hyperuricemia and other complications, which not only makes the treatment of the disease more difficult, but also increases the burden of the hospital. Therefore, to analyze the metabolic factors related to hyperfatemia, and to provide a reference for the clinical exploration of active and effective treatment